| 000 | 01057 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250511132146.0 | ||
| 264 | 0 | _c19771020 | |
| 008 | 197710s 0 0 eng d | ||
| 022 | _a0033-3158 | ||
| 024 | 7 |
_a10.1007/BF00426481 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHansen, L B | |
| 245 | 0 | 0 |
_aPlasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment. _h[electronic resource] |
| 260 |
_bPsychopharmacology _cJul 1977 |
||
| 300 |
_a127-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPerphenazine _xadministration & dosage |
| 650 | 0 | 4 |
_aPsychotic Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aSulfoxides _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLarsen, N E | |
| 773 | 0 |
_tPsychopharmacology _gvol. 53 _gno. 2 _gp. 127-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00426481 _zAvailable from publisher's website |
| 999 |
_c429465 _d429465 |
||